These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Frontline therapy for multiple myeloma: a concise review of the evidence based on randomized clinical trials.
    Author: Yaqub S, Ballester G, Ballester O.
    Journal: Cancer Invest; 2013 Oct; 31(8):529-37. PubMed ID: 24083815.
    Abstract:
    The past decade has seen significant progress in the development of new and effective therapies for multiple myeloma. Stem cell transplantation and the introduction of novel agents, such as thalidomide, lenalidomide, and bortezomib, have significantly improved outcomes of myeloma patients. In the current review, we analyzed the available data provided by published randomized clinical trials for the frontline therapy of myeloma patients. We attempted to assess the relative contribution and impact of these new therapies in the setting of both, transplant eligible and transplant ineligible patients.
    [Abstract] [Full Text] [Related] [New Search]